资讯

MedPage Today on MSN2 天
Alzheimer's Lecanemab Treatment Up to 36 Months Supported by Extension Study
SAN DIEGO -- Biomarker and cognitive data supported treatment with the anti-amyloid agent lecanemab (Leqembi) for up to 36 ...